|
Anybody have a working method for NTTP in Sitagliptin?
|
|
3
|
1051
|
April 6, 2023
|
|
Use of Multiple 3rd Party Laboratories for Testing
|
|
1
|
583
|
April 5, 2023
|
|
The true role of NitrXtes in NDSRIs?
|
|
2
|
454
|
April 3, 2023
|
|
Theoretical 'Purge Factor'
|
|
10
|
2268
|
March 31, 2023
|
|
Any method out there for N-Nitrosomethylphenidate
|
|
0
|
409
|
March 31, 2023
|
|
Korea FDA just published a compilation of analytical methods document!
|
|
13
|
2693
|
March 31, 2023
|
|
Ascend Laboratories LLC. is voluntarily recalling Dabigatran Etcxilate Capsules due to the presence of a NDSRI, N-nitroso-dabigatran, above the established Acceptable Daily Intake (ADI) level
|
|
5
|
990
|
March 30, 2023
|
|
N-Nitrosamines and their precursors in wastewater effluents from selected industries in Spain -Pub
|
|
0
|
322
|
March 29, 2023
|
|
Unofficial/official surrogates for read-across
|
|
5
|
2095
|
March 27, 2023
|
|
NDMA formation Due to Active Ingredient Degradation and Nitrite Traces in Drug Product
|
|
0
|
759
|
March 24, 2023
|
|
Computational Prediction of Metabolic α-Carbon Hydroxylation Potential of N-Nitrosamines: Overcoming Data Limitations for Carcinogenicity Assessment
|
|
5
|
894
|
March 23, 2023
|
|
Officially used surrogates for read-across method
|
|
14
|
2915
|
March 23, 2023
|
|
LoQ of 0.03 ppm
|
|
5
|
1340
|
March 15, 2023
|
|
NDSRI complex nitrosamine Accetable Intake methodology harmonisation by regulators may be followed in Early 2024
|
|
1
|
974
|
March 14, 2023
|
|
Limit for Nitroso Atenolol
|
|
6
|
1581
|
March 14, 2023
|
|
3-year work plan for EMA Nitrosamine Safety Operational Expert Group
|
|
0
|
544
|
March 11, 2023
|
|
The Landscape of Small and Drug Substance Related Nitrosamines in Pharmaceuticals
|
|
10
|
1823
|
March 8, 2023
|
|
U̶p̶c̶o̶m̶i̶n̶g̶ Nitrosamine Special Issue of JPS
|
|
3
|
1969
|
March 7, 2023
|
|
Testing of finished product when working with hard gelatin capsules
|
|
2
|
760
|
March 6, 2023
|
|
Solid State Kinetics of Nitrosation Using Native Sources of Nitrite -Pub
|
|
1
|
1088
|
March 6, 2023
|
|
UHPLC-APCI-TQ-MS analytical method capable of quantifying eight nitrosamine impurities from five different Metformin Formulations -Pub
|
|
1
|
913
|
March 2, 2023
|
|
确定DNSRI的限度需要同时进行Ames和致癌性实验吗？
|
|
4
|
563
|
March 2, 2023
|
|
Current threat of nitrosamines in pharmaceuticals and scientific strategies for risk mitigation -Pub
|
|
0
|
960
|
February 7, 2023
|
|
A Survey of Industrial N-nitrosamine Discharges in Switzerland -Pub
|
|
0
|
329
|
March 1, 2023
|
|
Health Canada - Guideline: Quality (CMC) Draft Guidance - New Drug Submissions & Abbreviated New Drug Submissions
|
|
0
|
1207
|
February 27, 2023
|
|
FDA updated compliance program guidance por inspections
|
|
1
|
711
|
February 27, 2023
|
|
👋🏻 Fantastic Regulatory Update Europe, US, LATAM
|
|
8
|
2402
|
February 25, 2023
|
|
Formation of Dialkyl-N-nitrosamines in Aqueous Solution: An Experimental Validation of a Conservative Predictive Model and a Comparison of the Rates of Dialkyl and Trialkylamine Nitrosation
|
|
6
|
1292
|
February 25, 2023
|
|
EMA Nitrosamine Q&A Rev14 published
|
|
6
|
1291
|
February 23, 2023
|
|
N-nitroso-propranolol?
|
|
18
|
2633
|
February 22, 2023
|